TY - JOUR
T1 - Whole-Genome sequencing uncovers the genetic basis of chronic mountain sickness in andean highlanders
AU - Zhou, Dan
AU - Udpa, Nitin
AU - Ronen, Roy
AU - Stobdan, Tsering
AU - Liang, Junbin
AU - Appenzeller, Otto
AU - Zhao, Huiwen W.
AU - Yin, Yi
AU - Du, Yuanping
AU - Guo, Lixia
AU - Cao, Rui
AU - Wang, Yu
AU - Jin, Xin
AU - Huang, Chen
AU - Jia, Wenlong
AU - Cao, Dandan
AU - Guo, Guangwu
AU - Gamboa, Jorge L.
AU - Villafuerte, Francisco
AU - Callacondo, David
AU - Xue, Jin
AU - Liu, Siqi
AU - Frazer, Kelly A.
AU - Li, Yingrui
AU - Bafna, Vineet
AU - Haddad, Gabriel G.
PY - 2013/9/5
Y1 - 2013/9/5
N2 - The hypoxic conditions at high altitudes present a challenge for survival, causing pressure for adaptation. Interestingly, many high-altitude denizens (particularly in the Andes) are maladapted, with a condition known as chronic mountain sickness (CMS) or Monge disease. To decode the genetic basis of this disease, we sequenced and compared the whole genomes of 20 Andean subjects (10 with CMS and 10 without). We discovered 11 regions genome-wide with significant differences in haplotype frequencies consistent with selective sweeps. In these regions, two genes (an erythropoiesis regulator, SENP1, and an oncogene, ANP32D) had a higher transcriptional response to hypoxia in individuals with CMS relative to those without. We further found that downregulating the orthologs of these genes in flies dramatically enhanced survival rates under hypoxia, demonstrating that suppression of SENP1 and ANP32D plays an essential role in hypoxia tolerance. Our study provides an unbiased framework to identify and validate the genetic basis of adaptation to high altitudes and identifies potentially targetable mechanisms for CMS treatment.
AB - The hypoxic conditions at high altitudes present a challenge for survival, causing pressure for adaptation. Interestingly, many high-altitude denizens (particularly in the Andes) are maladapted, with a condition known as chronic mountain sickness (CMS) or Monge disease. To decode the genetic basis of this disease, we sequenced and compared the whole genomes of 20 Andean subjects (10 with CMS and 10 without). We discovered 11 regions genome-wide with significant differences in haplotype frequencies consistent with selective sweeps. In these regions, two genes (an erythropoiesis regulator, SENP1, and an oncogene, ANP32D) had a higher transcriptional response to hypoxia in individuals with CMS relative to those without. We further found that downregulating the orthologs of these genes in flies dramatically enhanced survival rates under hypoxia, demonstrating that suppression of SENP1 and ANP32D plays an essential role in hypoxia tolerance. Our study provides an unbiased framework to identify and validate the genetic basis of adaptation to high altitudes and identifies potentially targetable mechanisms for CMS treatment.
UR - https://www.scopus.com/pages/publications/84883787441
U2 - 10.1016/j.ajhg.2013.07.011
DO - 10.1016/j.ajhg.2013.07.011
M3 - Artículo
C2 - 23954164
AN - SCOPUS:84883787441
SN - 0002-9297
VL - 93
SP - 452
EP - 462
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -